Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mass Drug Administration of Monthly DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique

NCT02914145 is registered in ClinicalTrials.gov with Centro de Investigacao em Saude de Manhica as lead sponsor.

NCT NCT02914145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02914145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mass Drug Administration of Monthly DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique
Lead sponsor
Centro de Investigacao em Saude de Manhica
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
December 31, 2017
Enrollment
240,502 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malaria